Follow DRNO on...
Private equity firm Symphony Technology Group (STG) has acquired patient and physician data provider Source Healthcare Analytics; and will combine it with its existing pharma offer to form a new division called Symphony Health Solutions. Terms of the deal were not disclosed. More
In the US, ImpactRx has acquired San Mateo, California-based pharma and biotech competitor AlphaDetail. Terms of the deal were not disclosed. More
In the US, pharma market research firm ImpactRx has appointed former IMS Health VP David Gascoigne, to lead the development of its Consulting and Analytics practice as EVP Consulting Analytics, Innovation and Alliances. More
In the US, pharma market research firm ImpactRx has acquired 100% of TargetRx, which helps pharmaceutical companies understand the drivers of physician behavior. Terms of the deal were not disclosed. More
In the US, pharma market research firm ImpactRx has appointed industry veteran Gregory Ellis as President and Chief Executive Officer, replacing Richard Altus who is leaving the firm just months after it was acquired by the parent of retail intelligence giant SymphonyIRI. More
In the US, physician panel specialist ImpactRX has upgraded its POP (point-of-promotion/point-of-prescribing) survey tool, to provide 'more streamlined' processing, faster client turnaround and more granular data capture. More
In the US, private equity firm Symphony Technology Group (STG) - the parent of retail market intelligence giant SymphonyIRI - has acquired a majority interest in physician panel provider ImpactRx. Financial terms of the transaction were not disclosed. More
In the US, physician panel provider ImpactRx has appointed former Merck exec Mark Degatano as Senior Vice President, Client Services Operations; and has expanded its range of specialist iPhone panels with the addition of pulmonologists. More
Online measurement firm comScore and pharma insights agency ImpactRx have launched a solution that links physicians' online and mobile behaviors with their actual prescription writing activities. More
US-based pharmaceutical data provider ImpactRx has formed a new unit to focus on the fast growing $20bn US oncology market. The new unit has launched ONCLink, a range of services to measure the effects of pharmaceutical promotion and education, and track physician behaviour and treatment decisions. More
Register (free) for Daily Research News
REGISTER FOR NEWS EMAILS
To receive (free) news headlines by email, please register online
